Anzeige
Mehr »
Freitag, 16.01.2026 - Börsentäglich über 12.000 News
Diese Goldaktie beschleunigt ihr Explorationsprogramm - Ergebnisse sprengen den Plan
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DoFirst Horizon stock price target raised to $28 by Raymond James on strong 4Q25
DoRaymond James reiterates Market Perform rating on Algonquin stock
DoJefferies raises Parsons stock price target to $80 on Altamira acquisition
DoBoston Scientific stock holds Buy rating at Needham after Penumbra acquisition
DoIpsos chairman Truchot steps down due to health reasons
DoNext plc to redeem B shares at 360 pence each following approval
DoRaymond James reiterates Outperform rating on HubSpot stock with $525 target
DoAltai Capital nominates two directors for OraSure Technologies board
DoAllstate stock price target lowered to $293 by BofA Securities
DoHSBC reduces stake in SSP Group to 9.25%
DoDisc Medicine stock rating reiterated by Morgan Stanley amid FDA review
DoTSMC stock price target raised to NT$2,360 by BofA on tech leadership
DoTaiwan Semi price target raised to $470 from $430 at BofA Securities
DoTSMC price target raised to NT$2,600 by Goldman Sachs on AI growth
DoMercury Insurance shares winter driving safety tips for motorists
DoGalaxy Digital stock gets ERCOT approval for 830 MW expansion at Helios
DoLong Path Partners to acquire Idox plc in all-cash deal
DoBit Origin announces 1-for-60 reverse stock split to maintain Nasdaq listing
DoREMSleep receives FDA clearance for expanded DeltaWave use
DoGoldman Sachs Q4 2025 slides: Strong EPS growth despite revenue miss
DoUnicorn AIM VCT declares 23p per share special dividend
DoiShares Digital Assets AG issues 880,000 Bitcoin ETP securities
DoTruist Securities reiterates Buy rating on Silgan Holdings stock
DoSimply Goods Group stock price target lowered to $30 at Mizuho
DoStifel remains bullish on Disc Medicine stock despite potential FDA delay